Disposition of 114 shares by Cindy Ferguson of ATRION at 617.1 subject to Rule 16b-3

Under 67% of ATRION's investor base is looking to short. The analysis of current outlook of investing in ATRION suggests that many traders are alarmed regarding ATRION's prospects. ATRION's investing sentiment shows overall attitude of investors towards ATRION.
  
Filed transaction by ATRION Officer Officer Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 114 restricted stock units at 617.1 of ATRION by Cindy Ferguson on 26th of August 2024. This event was filed by ATRION with SEC on 2027-01-21. Initial filing of beneficial ownership - SEC Form 3

ATRION Fundamental Analysis

We analyze ATRION's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRION using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRION based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

ATRION is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

ATRION Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ATRION stock to make a market-neutral strategy. Peer analysis of ATRION could also be used in its relative valuation, which is a method of valuing ATRION by comparing valuation metrics with similar companies.

Peers

ATRION Related Equities

MMSIMerit Medical   3.59   
0%
100.0%
HAEHaemonetics   1.44   
0%
40.0%
KRMDRepro Med   0.87   
0%
24.0%
ATRAptarGroup   0.77   
0%
21.0%
ATRCAtriCure   0.62   
0%
17.0%
NVSTEnvista Holdings   0.60   
0%
16.0%
COOCooper Companies,   0.57   
0%
15.0%
AKYAAkoya Biosciences   1.21   
33.0%
0%
ANGOAngioDynamics   1.59   
44.0%
0%
ICUIICU Medical   2.28   
63.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in ATRION Stock

If you are still planning to invest in ATRION check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATRION's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world